Hideki Ebihara

Author PubWeight™ 74.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 2007 10.40
2 Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol 2010 3.77
3 Human macrophage C-type lectin specific for galactose and N-acetylgalactosamine promotes filovirus entry. J Virol 2004 2.34
4 Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol 2006 2.24
5 Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013 1.97
6 Ebola virus VP40 late domains are not essential for viral replication in cell culture. J Virol 2005 1.97
7 Assembly and budding of Ebolavirus. PLoS Pathog 2006 1.62
8 Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol 2006 1.61
9 Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy. J Infect Dis 2011 1.47
10 Pandemic swine-origin H1N1 influenza A virus isolates show heterogeneous virulence in macaques. J Virol 2010 1.47
11 Generation of biologically contained Ebola viruses. Proc Natl Acad Sci U S A 2008 1.47
12 Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses. J Virol 2013 1.43
13 Detection of Lassa virus, Mali. Emerg Infect Dis 2010 1.41
14 Clinical outcome of henipavirus infection in hamsters is determined by the route and dose of infection. J Virol 2011 1.40
15 Protective efficacy of neutralizing antibodies against Ebola virus infection. Vaccine 2006 1.38
16 Rapid and simple detection of Ebola virus by reverse transcription-loop-mediated isothermal amplification. J Virol Methods 2006 1.35
17 Replication-deficient ebolavirus as a vaccine candidate. J Virol 2009 1.32
18 Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport. Cell Host Microbe 2008 1.31
19 Validation of assays to monitor immune responses in the Syrian golden hamster (Mesocricetus auratus). J Immunol Methods 2011 1.31
20 Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Arch Virol 2014 1.27
21 Vesicular stomatitis virus-based vaccine protects hamsters against lethal challenge with Andes virus. J Virol 2011 1.26
22 Identification of cell surface molecules involved in dystroglycan-independent Lassa virus cell entry. J Virol 2011 1.23
23 Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus. PLoS Pathog 2011 1.17
24 Epitopes required for antibody-dependent enhancement of Ebola virus infection. J Infect Dis 2007 1.16
25 The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog 2012 1.16
26 The Syrian hamster model of hantavirus pulmonary syndrome. Antiviral Res 2012 1.10
27 Use of vesicular stomatitis virus pseudotypes bearing hantaan or seoul virus envelope proteins in a rapid and safe neutralization test. Clin Diagn Lab Immunol 2003 1.09
28 Adenovirus vectors expressing hantavirus proteins protect hamsters against lethal challenge with andes virus. J Virol 2009 1.08
29 Clinical aspects of Marburg hemorrhagic fever. Future Virol 2011 1.06
30 Use of the Syrian hamster as a new model of ebola virus disease and other viral hemorrhagic fevers. Viruses 2012 1.04
31 Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus. J Infect Dis 2011 1.03
32 Detection of all known filovirus species by reverse transcription-polymerase chain reaction using a primer set specific for the viral nucleoprotein gene. J Virol Methods 2010 1.01
33 Cell fusion activities of Hantaan virus envelope glycoproteins. J Virol 2004 1.01
34 Ebola virus RNA editing depends on the primary editing site sequence and an upstream secondary structure. PLoS Pathog 2013 1.00
35 The multimerization of hantavirus nucleocapsid protein depends on type-specific epitopes. J Virol 2003 1.00
36 Antagonism of type I interferon responses by new world hantaviruses. J Virol 2010 1.00
37 Proteolytic processing of the Ebola virus glycoprotein is not critical for Ebola virus replication in nonhuman primates. J Virol 2007 1.00
38 New World hantaviruses activate IFNlambda production in type I IFN-deficient vero E6 cells. PLoS One 2010 0.98
39 In vitro and in vivo activity of ribavirin against Andes virus infection. PLoS One 2011 0.93
40 Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy. J Infect Dis 2013 0.93
41 Complete genome sequencing of four geographically diverse strains of Batai virus. J Virol 2012 0.92
42 Evolution of human Polyomavirus JC: implications for the population history of humans. J Mol Evol 2002 0.91
43 Protective efficacy of a bivalent recombinant vesicular stomatitis virus vaccine in the Syrian hamster model of lethal Ebola virus infection. J Infect Dis 2011 0.91
44 Hamster-adapted Sin Nombre virus causes disseminated infection and efficiently replicates in pulmonary endothelial cells without signs of disease. J Virol 2013 0.90
45 C-type lectins do not act as functional receptors for filovirus entry into cells. Biochem Biophys Res Commun 2010 0.90
46 Development of a minigenome system for Andes virus, a New World hantavirus. Arch Virol 2012 0.90
47 Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol 2011 0.89
48 Itaya virus, a Novel Orthobunyavirus Associated with Human Febrile Illness, Peru. Emerg Infect Dis 2015 0.85
49 Truncated hantavirus nucleocapsid proteins for serotyping Sin Nombre, Andes, and Laguna Negra hantavirus infections in humans and rodents. J Clin Microbiol 2010 0.84
50 Complete genome sequencing of mosquito and human isolates of Ngari virus. J Virol 2012 0.83
51 Arenavirus budding: a common pathway with mechanistic differences. Viruses 2013 0.83
52 Ebola virus does not block apoptotic signaling pathways. J Virol 2013 0.82
53 In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics. J Infect Dis 2007 0.78
54 Spatiotemporal analysis of Guaroa virus diversity, evolution, and spread in South America. Emerg Infect Dis 2015 0.76
55 Maguari Virus Associated with Human Disease. Emerg Infect Dis 2017 0.75